| Financial Year |
March 31 2023 |
| Monetary Funds |
470,278,888.56 |
| Held-for-trading Financial Assets |
2,748,537,000.00 |
| Notes Receivable |
2,900,000.00 |
| Accounts Receivable |
730,533,952.68 |
| Advances to Suppliers |
26,054,408.79 |
| Other Receivables |
42,458,121.27 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
92,683,986.65 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
13,443,189.58 |
| Total Current Assets |
4,179,807,837.28 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
35,657,929.27 |
| Investment Properties |
-- |
| Fixed Assetes |
496,210,610.53 |
| Under-construction Projects |
17,130,075.10 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
51,126,198.39 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
34,348,265.93 |
| Deferred Income Tax Assets |
58,384,647.58 |
| Other Non-Current Assets |
25,772,619.86 |
| Sub-Total of Non-Current Assets |
749,806,767.06 |
| Total Assets |
4,929,614,604.34 |
| Short-Term Loans |
180,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
39,599,400.00 |
| Accounts Payable |
123,758,769.80 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
15,151,832.77 |
| Taxes Payable |
12,101,454.14 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
231,217,511.26 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,244,023.92 |
| Other Current Liabilities |
3,861,502.36 |
| Sub-Total of Current Liabilities |
642,644,754.08 |
| Long-term Loans |
-- |
| Bonds Payable |
609,597,274.87 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
8,240,488.34 |
| Deferred Income Tax Liabilities |
317,437,176.87 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
939,337,322.47 |
| Total Liabilities |
1,581,982,076.55 |
| Paid-In Capital(Or Share Stock) |
232,656,780.00 |
| Capital Surplus |
730,427,051.01 |
| Surplus Reserve |
118,679,816.89 |
| LESS:Treasury Stock |
49,952,138.68 |
| Undistributed Profits |
2,092,406,667.83 |
| Minority Stockholder's Interest |
22,361,146.90 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,325,271,380.89 |
| Owner's Equity（Stockholder's Equity） |
3,347,632,527.79 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,929,614,604.34 |
